BCRX - BioCryst Pharmaceuticals beats top-line and bottom-line estimates; updates FY24 outlook May, 06 2024 07:04 AM BioCryst Pharmaceuticals Inc. 2024-05-06 07:04:28 ET More on BioCryst Pharmaceuticals BioCryst's Revenue Gains Offset By Rising Expenses: A Closer Look BioCryst Pharmaceuticals reports Q4 results Seeking Alpha’s Quant Rating on BioCryst Pharmaceuticals For further details see: BioCryst Pharmaceuticals beats top-line and bottom-line estimates; updates FY24 outlook